These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16679429)

  • 21. Risk versus benefit considerations for the beta(2)-agonists.
    Kelly HW
    Pharmacotherapy; 2006 Sep; 26(9 Pt 2):164S-74S. PubMed ID: 16945063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrasting properties of albuterol stereoisomers.
    Page CP; Morley J
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S31-41. PubMed ID: 10452786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preserved bronchial dilatation after salbutamol does not guarantee protection against bronchial hyperresponsiveness.
    Sjöswärd KN; Josefsson M; Ahlner J; Schmekel B
    Clin Physiol Funct Imaging; 2003 Jan; 23(1):14-20. PubMed ID: 12558609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Albuterol enantiomers: pre-clinical and clinical value?
    Ameredes BT; Calhoun WJ
    Front Biosci (Elite Ed); 2010 Jun; 2(3):1081-92. PubMed ID: 20515778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacokinetics of levosalbutamol: what are the clinical implications?
    Boulton DW; Fawcett JP
    Clin Pharmacokinet; 2001 Jan; 40(1):23-40. PubMed ID: 11236808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol.
    Milgrom H; Skoner DP; Bensch G; Kim KT; Claus R; Baumgartner RA;
    J Allergy Clin Immunol; 2001 Dec; 108(6):938-45. PubMed ID: 11742271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes and treatment cost comparison of levalbuterol versus albuterol in hospitalized adults with chronic obstructive pulmonary disease or asthma.
    Brunetti L; Poiani G; Dhanaliwala F; Poppiti K; Kang H; Suh DC
    Am J Health Syst Pharm; 2015 Jun; 72(12):1026-35. PubMed ID: 26025994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A patient satisfaction survey comparing levalbuterol with racemic albuterol in children.
    Berger WE; Ames DE; Harrison D
    Allergy Asthma Proc; 2004; 25(6):437-44. PubMed ID: 15709455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma.
    Hamilos DL; D'Urzo A; Levy RJ; Marcus M; Tripp K; Parsey M; Baumgartner RA; McVicar WK
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):540-8. PubMed ID: 18219836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects.
    Tripp K; McVicar WK; Nair P; Corren J; Pleskow WW; Goodwin E; Baumgartner RA; Hanrahan JP
    J Allergy Clin Immunol; 2008 Sep; 122(3):544-9. PubMed ID: 18692886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-isomer levalbuterol: a review of the acute data.
    Nowak R
    Curr Allergy Asthma Rep; 2003 Mar; 3(2):172-8. PubMed ID: 12562558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Question from the clinician: levalbuterol in managing pediatric asthma.
    Abbott MB; Levin RH; Miller JA
    Pediatr Rev; 2002 Nov; 23(11):401-3. PubMed ID: 12415020
    [No Abstract]   [Full Text] [Related]  

  • 33. Levalbuterol inhibits human airway smooth muscle cell proliferation: therapeutic implications in the management of asthma.
    Ibe BO; Portugal AM; Raj JU
    Int Arch Allergy Immunol; 2006; 139(3):225-36. PubMed ID: 16446544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levalbuterol versus albuterol for acute asthma: a systematic review and meta-analysis.
    Jat KR; Khairwa A
    Pulm Pharmacol Ther; 2013 Apr; 26(2):239-48. PubMed ID: 23207739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.
    Donohue JF; Wise R; Busse WW; Garfinkel S; Zubek VB; Ghafouri M; Manuel RC; Schlenker-Herceg R; Bleecker ER
    BMC Pulm Med; 2016 Apr; 16(1):65. PubMed ID: 27130202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levosalbutamol in the treatment of asthma.
    Milgrom H
    Expert Opin Pharmacother; 2006 Aug; 7(12):1659-68. PubMed ID: 16872269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
    Sin DD; Man SF
    Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is new with the beta2-agonists: issues in the management of asthma.
    Kelly HW
    Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of racemic albuterol and levalbuterol for treatment of acute asthma.
    Carl JC; Myers TR; Kirchner HL; Kercsmar CM
    J Pediatr; 2003 Dec; 143(6):731-6. PubMed ID: 14657817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-isomer beta-agonists.
    Handley DA
    Pharmacotherapy; 2001 Mar; 21(3 Pt 2):21S-27S. PubMed ID: 11253864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.